Senator Marco Rubio (R-FL) reportedly wrote a letter to FDA Commissioner Robert Califf and DHS Secretary Alejandro Mayorkas, requesting that they ensure that products imported to the United States are not produced using slave labor.
Rubio introduced the Uyghur Forced Labor Prevention Act (UFLPA) in 2021, and it was subsequently enacted into law.
The Act would guarantee that products manufactured with the slave labor of Uyghurs and other predominantly Muslim ethnic groups in the Xinjiang Uyghur Autonomous Region and other regions of the People’s Republic of China are not imported into the United States.
In his letter Rubio claimed that “recent reports identifying two pharmaceutical producers based in the Xinjiang Uyghur Autonomous Region (XUAR) of the People’s Republic of China (PRC) that are permitted by the U.S. Food and Drug Administration (FDA) to distribute their products in the U.S.”
“This is in clear violation of current law which prohibits imports from the region due to the Chinese Communist Party’s (CCP) egregious human rights abuses, including genocide, forced abortions, and forced sterilizations.” he added.
“Recent analysis by the Centers for Advanced Defense Studies exposed that the FDA currently allows at least two pharmaceutical producers, Xinjiang Nuziline Bio-Pharmaceutical Co. and SEL Biochem Xinjiang Co. to import APIs and drug products into the U.S. Both of these companies are linked to slave labor in Xinjiang and are not listed on the UFLPA Entity List.” he continued.
“The Uyghur Forced Labor Prevention Act assures the American people that the products they purchase were made without slave labor.” Rubio concluded.
[READ MORE: Iran Preparing Major Attack on Israel before Election Day]
